UK Markets closed

GlaxoSmithKline plc (GSK)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
43.74+0.06 (+0.13%)
As of 03:28PM EDT. Market open.
Full screen
Loading interactive chart…
  • Zacks

    Gilead (GILD) Announces Positive Data on Hepcludex for HDV

    Gilead (GILD) Hepcludex meets the primary endpoint in a phase III study for the treatment of chronic hepatitis delta virus (HDV) infection at 48 weeks.

  • Zacks

    GlaxoSmithKline (GSK) Gains As Market Dips: What You Should Know

    GlaxoSmithKline (GSK) closed at $41.97 in the latest trading session, marking a +0.48% move from the prior day.

  • Motley Fool

    Buy the Dip on These 3 Healthcare Stocks

    With the S&P 500 down over 23% year to date, investors looking for safety are eyeing the healthcare industry. Taylor Carmichael (Vir Biotechnology): Vir Bio is down about 45% in 2022, but it is one of my highest-confidence positions in healthcare right now. When the Food and Drug Administration gave Vir -- and its partner, GlaxoSmithKline -- an Emergency Use Authorization (EUA) for its COVID-19 treatment sotrovimab (trademark Xevudy), demand for the drug skyrocketed.